| 1 |
31857520 |
10.4103/ijdvl.IJDVL_1011_18 |
2022 |
Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study. |
TOX |
| 2 |
33608984 |
10.1111/ajco.13545 |
2022 |
Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma. |
TOX |
| 3 |
33785299 |
10.1016/j.clml.2021.02.014 |
2022 |
Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical Practice. |
TOX |
| 4 |
34852226 |
10.1016/j.celrep.2021.110079 |
2022 |
CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia. |
TOX |
| 5 |
35111387 |
10.1080/2162402X.2022.2033433 |
2022 |
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma. |
TOX |
| 6 |
35203244 |
10.3390/cells11040593 |
2022 |
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma. |
TOX |
| 7 |
35642346 |
10.5146/tjpath.2022.01578 |
2022 |
TOX Outperforms FOXP3, CD4 and GATA3 in Histopathological Diagnosis of Early Mycosis Fungoides. |
TOX |
| 8 |
35679527 |
10.1080/10428194.2022.2081326 |
2022 |
TCF1 and Tox define different subsets of CD4 T cells in patients with Sézary syndrome. |
TOX |
| 9 |
35704047 |
10.1007/s00204-022-03322-1 |
2022 |
Genotoxicity of methyl acrylate and ethyl acrylate and its relationship with glutathione. |
TOX |
| 10 |
35713502 |
10.1093/rheumatology/keac304 |
2022 |
TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome. |
TOX |
| 11 |
35885488 |
10.3390/diagnostics12071582 |
2022 |
TOX Expression in Mycosis Fungoides and Sezary Syndrome. |
TOX |
| 12 |
25941598 |
10.4161/21624011.2014.970025 |
2021 |
Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma. |
TOX |
| 13 |
28638728 |
10.1080/2162402X.2017.1306618 |
2021 |
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. |
TOX |
| 14 |
30221071 |
10.1080/2162402X.2018.1467856 |
2021 |
Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients. |
TOX |
| 15 |
31676945 |
10.1007/s00403-019-02000-0 |
2021 |
Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma. |
TOX |
| 16 |
32554312 |
10.1016/j.anndiagpath.2020.151546 |
2021 |
Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. |
TOX |
| 17 |
32859220 |
10.1186/s12977-020-00535-z |
2021 |
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma. |
TOX |
| 18 |
33112366 |
10.1001/jamadermatol.2020.3958 |
2021 |
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis. |
TOX |
| 19 |
33314029 |
10.1111/bjd.19719 |
2021 |
The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort. |
TOX |
| 20 |
33356863 |
10.1080/10934529.2020.1861903 |
2021 |
Indoor volatile organic compounds exposures and risk of childhood acute leukemia: a case-control study in shanghai. |
TOX |
| 21 |
33400272 |
10.1111/bjd.19796 |
2021 |
Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome. |
TOX |
| 22 |
33941102 |
10.1186/s12885-021-08142-7 |
2021 |
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. |
TOX |
| 23 |
34220814 |
10.3389/fimmu.2021.668369 |
2021 |
NLRP3 Regulates IL-4 Expression in TOX<sup>+</sup> CD4<sup>+</sup> T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression. |
TOX |
| 24 |
34885092 |
10.3390/cancers13235982 |
2021 |
Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4<sup>+</sup> BTLA<sup>+</sup> T Cells in Tumor Microenvironment of Mycosis Fungoides. |
TOX |
| 25 |
31139323 |
10.18632/oncotarget.5742 |
2020 |
Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma. |
TOX |
| 26 |
31489115 |
10.18632/oncotarget.27120 |
2020 |
Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes. |
TOX |
| 27 |
31554191 |
10.3390/molecules24193459 |
2020 |
Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas. |
TOX |
| 28 |
32106280 |
10.1371/journal.pone.0229743 |
2020 |
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations. |
TOX |
| 29 |
11864246 |
10.1111/j.1469-0691.1998.tb00040.x |
2019 |
HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus. |
TOX |
| 30 |
12563341 |
|
2019 |
NTP Toxicology and Carcinogenesis Studies of Glutaraldehyde (CAS NO. 111-30-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). |
TOX |
| 31 |
30747224 |
10.3892/mmr.2019.9885 |
2019 |
miRNA‑135a regulates Hut78 cell proliferation via the GATA‑3/TOX signaling pathway. |
TOX |
| 32 |
30786062 |
10.1002/em.22278 |
2019 |
Critical review of styrene genotoxicity focused on the mutagenicity/clastogenicity literature and using current organization of economic cooperation and development guidance. |
TOX |
| 33 |
28489605 |
10.18632/oncotarget.17383 |
2018 |
Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome. |
TOX |
| 34 |
28974511 |
10.1158/2159-8290.CD-17-0267 |
2018 |
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia. |
TOX |
| 35 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
TOX |
| 36 |
26518733 |
10.1111/ijd.13080 |
2017 |
Two cases of CD8-positive hypopigmented mycosis fungoides without TOX expression. |
TOX |
| 37 |
26931394 |
10.1111/bjd.14508 |
2017 |
TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+) CD8(-) phenotype. |
TOX |
| 38 |
27180090 |
10.1007/s00403-016-1654-7 |
2017 |
TOX expression in cutaneous B-cell lymphomas. |
TOX |
| 39 |
27345620 |
10.1111/jdv.13651 |
2017 |
TOX expression and role in CTCL. |
TOX |
| 40 |
27535602 |
10.1111/bjd.14683 |
2017 |
TOX - what role does it play in cutaneous lymphomas? |
TOX |
| 41 |
27759688 |
10.1097/DAD.0000000000000537 |
2017 |
An Index Case of Concomitant Tumoral and Ichthyosiform Mycosis Fungoides-Like Presentation of Chronic Adult T-cell Leukemia/Lymphoma Associated With Upregulation of TOX. |
TOX |
| 42 |
27766406 |
10.1007/s00403-016-1698-8 |
2017 |
CD164 identifies CD4<sup>+</sup> T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. |
TOX |
| 43 |
24844359 |
10.3109/10428194.2014.924119 |
2016 |
Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset. |
TOX |
| 44 |
25777533 |
10.1111/cup.12490 |
2016 |
Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis. |
TOX |
| 45 |
25779945 |
10.1158/1078-0432.CCR-14-3322 |
2016 |
The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL). |
TOX |
| 46 |
25811617 |
10.1371/journal.pone.0117479 |
2016 |
TOX acts an oncological role in mycosis fungoides. |
TOX |
| 47 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2016 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
TOX |
| 48 |
26972187 |
10.1111/ddg.12900 |
2016 |
Sézary syndrome: old enigmas, new targets. |
TOX |
| 49 |
24947046 |
10.18632/oncotarget.2031 |
2015 |
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. |
TOX |
| 50 |
25216799 |
10.1007/s00403-014-1501-7 |
2015 |
TOX expression in different subtypes of cutaneous lymphoma. |
TOX |
| 51 |
25261097 |
10.3324/haematol.2014.112912 |
2015 |
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. |
TOX |
| 52 |
25548321 |
10.1182/blood-2014-05-571778 |
2015 |
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. |
TOX |
| 53 |
25628470 |
10.1182/blood-2014-07-590398 |
2015 |
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. |
TOX |
| 54 |
25721042 |
10.1182/blood-2015-01-621169 |
2015 |
Malignant TOXication of T cells. |
TOX |
| 55 |
23812212 |
|
2014 |
Targeting cancer with a bi-functional peptide: in vitro and in vivo results. |
TOX |
| 56 |
23859824 |
10.1016/j.mcn.2013.07.004 |
2014 |
C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis. |
TOX |
| 57 |
24304814 |
10.1038/jid.2013.461 |
2014 |
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. |
TOX |
| 58 |
22837180 |
10.1158/1078-0432.CCR-12-0845 |
2013 |
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. |
TOX |
| 59 |
22377759 |
10.1038/jid.2012.13 |
2012 |
Molecular markers of early-stage mycosis fungoides. |
TOX |
| 60 |
21562036 |
10.1158/1078-0432.CCR-11-0395 |
2011 |
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. |
TOX |
| 61 |
20104439 |
10.1055/s-0029-1244835 |
2010 |
[Nausea, diarrhea and paraumbilical flow murmur after ileum resection. Arteriovenous fistula of the superior mesenteric artery]. |
TOX |
| 62 |
16782810 |
10.1073/pnas.0603728103 |
2006 |
Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. |
TOX |
| 63 |
14533916 |
10.1081/ese-120024449 |
2004 |
Teratogenic effect of broad-band electromagnetic field on neonatal mice (Mus musculus). |
TOX |
| 64 |
11344042 |
10.1016/s1383-5742(01)00055-2 |
2001 |
A review of the genotoxicity of marketed pharmaceuticals. |
TOX |
| 65 |
10708987 |
10.1016/s1383-5718(99)00186-2 |
2000 |
Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database. |
TOX |
| 66 |
10365510 |
|
1999 |
[Typification of strains of Helicobacter pylori by the detection of the cagA gene and subtypes of the vacA gene]. |
TOX |
| 67 |
9434856 |
10.1016/s1383-5718(97)00115-0 |
1998 |
The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. |
TOX |
| 68 |
1373840 |
10.1016/0027-5107(92)90173-y |
1992 |
Simultaneous evaluation of genotoxicity data from different sources: a multivariate statistical approach. |
TOX |
| 69 |
580785 |
10.1093/infdis/137.6.747 |
1978 |
Isolation of nontoxinogenic mutants of Vibrio cholerae in a colorimetric assay for cholera toxin using the S49 mouse lymphosarcoma cell line. |
TOX |
Datasets
Models
